ATE250399T1 - Gebrauch von autologen, dermalen fibroblasten zur reperatur von haut- oder weichgewebeschäden - Google Patents

Gebrauch von autologen, dermalen fibroblasten zur reperatur von haut- oder weichgewebeschäden

Info

Publication number
ATE250399T1
ATE250399T1 AT96923640T AT96923640T ATE250399T1 AT E250399 T1 ATE250399 T1 AT E250399T1 AT 96923640 T AT96923640 T AT 96923640T AT 96923640 T AT96923640 T AT 96923640T AT E250399 T1 ATE250399 T1 AT E250399T1
Authority
AT
Austria
Prior art keywords
autological
dermal fibroblasts
soft tissue
tissue damage
repair skin
Prior art date
Application number
AT96923640T
Other languages
English (en)
Inventor
William K Boss Jr
Original Assignee
Isolagen Internat S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isolagen Internat S A filed Critical Isolagen Internat S A
Application granted granted Critical
Publication of ATE250399T1 publication Critical patent/ATE250399T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0059—Cosmetic or alloplastic implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3869—Epithelial tissues other than skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/901—Method of manufacturing prosthetic device
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/902—Method of implanting
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/915—Method or apparatus for preparing biological material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/92—Method or apparatus for preparing or treating prosthetic
    • Y10S623/923—Bone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Birds (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
AT96923640T 1995-07-28 1996-07-03 Gebrauch von autologen, dermalen fibroblasten zur reperatur von haut- oder weichgewebeschäden ATE250399T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/508,773 US5591444A (en) 1995-07-28 1995-07-28 Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects
PCT/US1996/011272 WO1997004720A1 (en) 1995-07-28 1996-07-03 The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects

Publications (1)

Publication Number Publication Date
ATE250399T1 true ATE250399T1 (de) 2003-10-15

Family

ID=24024016

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96923640T ATE250399T1 (de) 1995-07-28 1996-07-03 Gebrauch von autologen, dermalen fibroblasten zur reperatur von haut- oder weichgewebeschäden

Country Status (18)

Country Link
US (4) US5591444A (de)
EP (2) EP1358857A1 (de)
JP (2) JP3559566B2 (de)
KR (1) KR100417896B1 (de)
CN (1) CN100349556C (de)
AT (1) ATE250399T1 (de)
AU (1) AU698440B2 (de)
BR (1) BR9610028A (de)
CA (1) CA2228138C (de)
DE (1) DE69630129T2 (de)
DK (1) DK0845963T3 (de)
ES (1) ES2207679T3 (de)
IL (1) IL123077A (de)
MX (1) MX9800788A (de)
NO (1) NO317738B1 (de)
NZ (1) NZ312548A (de)
PT (1) PT845963E (de)
WO (1) WO1997004720A1 (de)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998036704A1 (en) * 1997-02-20 1998-08-27 Keller Gregory S Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects
AU740113B2 (en) * 1997-02-20 2001-11-01 Gerigene Medical Corporation Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects
US7767452B2 (en) * 1997-02-20 2010-08-03 Kleinsek Don A Tissue treatments with adipocyte cells
US6398753B2 (en) 1998-04-03 2002-06-04 Mcdaniel David H. Ultrasound enhancement of percutaneous drug absorption
US6030374A (en) * 1998-05-29 2000-02-29 Mcdaniel; David H. Ultrasound enhancement of percutaneous drug absorption
US7115417B1 (en) 1998-05-01 2006-10-03 Chancellor Michael B Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof
US6866842B1 (en) 1998-05-01 2005-03-15 University Of Pittsburgh Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
US6432710B1 (en) * 1998-05-22 2002-08-13 Isolagen Technologies, Inc. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
AU4093399A (en) * 1998-05-22 1999-12-13 Isolagen Technologies, Inc. Compositions for regenerating tissue that has degenerated, and methods for using such compositions
US7004933B2 (en) 1998-05-29 2006-02-28 Light Bioscience L.L.C. Ultrasound enhancement of percutaneous drug absorption
US6274090B1 (en) * 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
US6663659B2 (en) 2000-01-13 2003-12-16 Mcdaniel David H. Method and apparatus for the photomodulation of living cells
US6283956B1 (en) * 1998-11-30 2001-09-04 David H. McDaniels Reduction, elimination, or stimulation of hair growth
US6887260B1 (en) 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US9192780B2 (en) * 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
US6936044B2 (en) * 1998-11-30 2005-08-30 Light Bioscience, Llc Method and apparatus for the stimulation of hair growth
US20060212025A1 (en) * 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
US6676655B2 (en) 1998-11-30 2004-01-13 Light Bioscience L.L.C. Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen
WO2001032129A2 (en) * 1999-11-05 2001-05-10 Gerigene Medical Corporation Augmentation and repair of age-related soft tissue defects
US20090074729A2 (en) * 1999-11-05 2009-03-19 Donald Kleinsek Augmentation and repair of spincter defects with cells including fibroblasts
US20080286242A2 (en) * 1999-11-05 2008-11-20 Donald Kleinsek Augmentation and repair of spincter defects with cells including mesenchymal cells
US7799325B2 (en) * 1999-11-05 2010-09-21 Kleinsek Donald A Removal of hypertrophic scars
US20080267923A2 (en) * 1999-11-05 2008-10-30 Donald Kleinsek Hair undifferentiated cells
ATE365045T1 (de) 2000-04-14 2007-07-15 Univ Pittsburgh Vermehrung des weich- sowie des knochengewebes anhand von aus muskeln stammenden vorläuferzellen,sowie damit verbundene zusammensetzungen und behandlungsformen
JP4017977B2 (ja) 2000-08-08 2007-12-05 アデランス リサーチ インスティテュート インコーポレイテッド 組織工学で処置した毛髪用の台
US20090130066A1 (en) * 2000-11-06 2009-05-21 Gerigene Medical Corporation Augmentation and repair of sphincter defects with cells including muscle cells
JP4680483B2 (ja) * 2001-02-23 2011-05-11 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 組織および臓器の治療および修復に用いるための幹細胞マトリックスの迅速な調製方法
GB0105899D0 (en) * 2001-03-09 2001-04-25 Intercytex Ltd Fibrosis reduction treatment
US8501396B2 (en) 2001-11-05 2013-08-06 Medgenics Medical Israel Ltd. Dermal micro-organs, methods and apparatuses for producing and using the same
US7468242B2 (en) 2001-11-05 2008-12-23 Medgenics, Inc. Dermal micro organs, methods and apparatuses for producing and using the same
US8088568B2 (en) 2001-11-05 2012-01-03 Medgentics, Inc. Dermal micro-organs, methods and apparatuses for producing and using the same
RU2308954C2 (ru) * 2002-05-09 2007-10-27 Медиджинез Фармацевтическая композиция для лечения ран, содержащая плазму или сыворотку крови
US20040101959A1 (en) * 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells
JP2006522660A (ja) * 2003-04-10 2006-10-05 ライト バイオサイエンス，エルエルシー 細胞増殖及び遺伝子発現を調節するためのフォトモジュレーション方法及び装置
EP2289526B1 (de) * 2003-04-25 2014-06-11 The University of Pittsburgh Muskeln abstammande zellen zur wiederherstellung und regenerierung nach nervenschädigung
EP1653807B1 (de) * 2003-05-01 2012-05-23 Medgenics, Inc. Verwendung von dermismikroorgane
US7186557B2 (en) * 2003-06-13 2007-03-06 Isolagen Technologies, Inc. Methods of producing neurons
CN1297324C (zh) * 2003-07-25 2007-01-31 吕伟光 组织工程自体复合皮肤及其制备方法
EP1648385B1 (de) * 2003-07-31 2016-05-04 Gentlewaves Llc System und verfahren für die photodynamische behandlung von haut
WO2005035738A1 (en) * 2003-10-07 2005-04-21 Biomaster Inc. Cell differentiation of adipose-derived precursor cells
WO2005046447A2 (en) * 2003-11-10 2005-05-26 Symphony Medical, Inc. Method to control ventricular rate in atrial fibrillation patients
US20070122906A1 (en) * 2003-12-29 2007-05-31 Allan Mishra Method of culturing cells
CA2555396C (en) * 2004-02-06 2016-03-15 Daniel Barolet Method and device for the treatment of mammalian tissues
US8765169B2 (en) * 2004-02-13 2014-07-01 Smith & Nephew, Inc. Wound healing profile
US7597885B2 (en) 2004-03-26 2009-10-06 Aderans Research Institute, Inc. Tissue engineered biomimetic hair follicle graft
KR100680134B1 (ko) 2004-06-10 2007-02-08 박우삼 무세포 진피를 주사가능하도록 입자 형태로 가공한 필러
KR100614903B1 (ko) * 2004-08-06 2006-08-25 테고사이언스 (주) 케라티노사이트 및/또는 섬유아세포를 함유하는 화장용조성물
AU2005273077B2 (en) * 2004-08-16 2011-02-24 Cellresearch Corporation Pte Ltd Isolation of stem/progenitor cells from amniotic membrane of umbilical cord.
FR2874503B1 (fr) * 2004-09-01 2006-11-24 Soc Ind Limousine Dapplication Biologique Silab Procede d'obtention d'un principe actif raffermissant et a visee anti-vergetures, actif obtenu et les fonctionnalites
GB0505202D0 (en) * 2005-03-14 2005-04-20 Intercytex Ltd Skin equivalent culture
RU2277423C1 (ru) * 2005-04-07 2006-06-10 Андрей Валентинович Васильев Способ коррекции структурно-функциональных изменений соединительной ткани
US20080199440A1 (en) * 2005-05-26 2008-08-21 Mike Leek Tissue Repair Using Allogenic Dermal Fibroblasts
EP2662439A1 (de) 2005-05-27 2013-11-13 Viacord, LLC Behandlung von Ischämie mit Stammzellen
WO2007001016A1 (ja) * 2005-06-29 2007-01-04 National University Corporation Nagoya University 皮膚組織改善材及びその利用
US20070065415A1 (en) * 2005-09-16 2007-03-22 Kleinsek Donald A Compositions and methods for the augmentation and repair of defects in tissue
AR057629A1 (es) 2005-11-22 2007-12-05 Aderans Res Inst Inc Injerto de foliculos pilosos de piel obtenida por ingenieria de tejidos
CN100421731C (zh) * 2006-01-11 2008-10-01 黄靖西 人自体胶原蛋白活细胞注射剂及其制备方法
CN102600548A (zh) 2006-02-09 2012-07-25 阿德兰斯研究学院有限公司 测微计辅助流体输送装置
RU2308957C1 (ru) * 2006-03-24 2007-10-27 Общество с ограниченной ответственностью "Медицинские технологии" Способ получения препарата для мезотерапии и препарат, полученный этим способом (варианты)
GB2440908A (en) * 2006-05-25 2008-02-20 Intercytex Ltd Tissue Repair and Augmentation
CN100415307C (zh) * 2006-05-30 2008-09-03 中国人民解放军第二军医大学 人成纤维细胞修饰的异体或异种脱细胞真皮替代物
TR200602727A2 (tr) * 2006-05-31 2007-12-24 Tun� T�Ryak� Kemal Cilt defektleri ve yaşlanması tedavisinde kullanılacak bir yöntem ve bir doku maddesi
KR20070122316A (ko) * 2006-06-26 2007-12-31 (주) 에스바이오메딕스 주사용 인체 연조직 충전제 및 이의 제조 방법
KR20070122315A (ko) * 2006-06-26 2007-12-31 (주) 에스바이오메딕스 자가 진피 세포 및 히알루론산을 함유하는 주사용 인체연조직 충전제 조성물
US8728819B2 (en) * 2006-08-29 2014-05-20 Fibrocell Technologies, Inc. Methods for culturing minimally-passaged fibroblasts and uses thereof
US8454948B2 (en) 2006-09-14 2013-06-04 Medgenics Medical Israel Ltd. Long lasting drug formulations
US9127084B2 (en) 2006-09-14 2015-09-08 Medgenics Medical Israel Ltd. Long lasting drug formulations
CN102886052B (zh) 2006-09-14 2014-07-30 迈德詹尼克斯医疗以色列有限公司 长效药物制剂
WO2008066886A2 (en) * 2006-11-28 2008-06-05 University Of Pittsburgh Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same
WO2008069376A1 (en) * 2006-12-07 2008-06-12 Jun-Ho Shin Culture method of fibroblast using autologous serum mixed with placenta extract and composition for skin regeneration using the same
US9121009B2 (en) * 2006-12-18 2015-09-01 University of Pittsburgh—Of the Commonweath System of Higher Education Muscle derived cells for the treatment of gastro-esophageal pathologies and methods of making and using the same
US20100158875A1 (en) 2006-12-18 2010-06-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Muscle derived cells for the treatment of gastro-esophageal pathologies and methods of making and using the same
JP4247333B2 (ja) * 2006-12-28 2009-04-02 国立大学法人名古屋大学 皮膚組織改善材およびその製造方法
EP2118271B1 (de) * 2007-01-11 2018-04-18 University of Pittsburgh - Of the Commonwealth System of Higher Education Zellen aus muskeln zur behandlung von harnwegserkrankungen sowie verfahren zu ihrer herstellung und verwendung
RU2345781C2 (ru) * 2007-01-22 2009-02-10 Олег Германович Макеев Способ получения культуры клеток кожи
WO2008136183A1 (ja) * 2007-04-28 2008-11-13 Applied Cell Biotechnologies, Inc. 皮膚または歯肉の軟組織の欠損を補修するための組成物，及び自己線維芽細胞の培養方法
US7985537B2 (en) 2007-06-12 2011-07-26 Aderans Research Institute, Inc. Methods for determining the hair follicle inductive properties of a composition
WO2009128076A2 (en) 2008-04-18 2009-10-22 Collplant Ltd. Methods of generating and using procollagen
US9199003B2 (en) * 2008-08-18 2015-12-01 University of Pittsburgh—of the Commonwealth System of Higher Education Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof
EP2182055A1 (de) 2008-10-14 2010-05-05 Heinrich-Heine-Universität Düsseldorf Aus der menschlichen Nabelschnur gewonnene unrestringierte somatische Stammzellen (USSC)
US20100233138A1 (en) * 2008-11-07 2010-09-16 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Vocal Cord Augmentation Utilizing Muscle-Derived Progenitor Compositions, and Treatments Thereof
RU2380106C1 (ru) * 2009-01-20 2010-01-27 Владимир Валентинович Давыденко Способ коррекции возрастных изменений кожи
FR2948286B1 (fr) * 2009-07-27 2011-08-26 Jean-Noel Thorel Composition injectable associant un agent de comblement et un milieu de croissance des fibroblastes
WO2011075676A2 (en) 2009-12-18 2011-06-23 Knowlton Edward W A skin treatment and drug delivery device
US8529883B2 (en) 2010-05-07 2013-09-10 Fibrocell Technologies, Inc. Dosage unit formulations of autologous dermal fibroblasts
KR20130041103A (ko) * 2010-06-30 2013-04-24 진시 첸 피부조직세포 응집체의 제조방법과 및 그 용도
US10736653B2 (en) 2013-12-06 2020-08-11 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US10856900B2 (en) 2010-12-17 2020-12-08 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US10702684B2 (en) 2010-12-17 2020-07-07 Srgi Holdings, Llc Systems, devices and methods for fractional resection, fractional skin grafting, fractional scar reduction and fractional tattoo removal
US10368904B2 (en) 2013-12-06 2019-08-06 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US10967162B2 (en) 2010-12-17 2021-04-06 Srgi Holdings, Llc Systems, devices and methods for fractional resection, fractional skin grafting, fractional scar reduction and fractional tattoo removal
US11000310B2 (en) 2010-12-17 2021-05-11 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US11278309B2 (en) 2010-12-17 2022-03-22 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US11103275B2 (en) 2010-12-17 2021-08-31 Srgi Holdings, Llc Pixel array medical systems, devices and methods
CN103083727A (zh) * 2011-11-07 2013-05-08 北京清美联创干细胞科技有限公司 一种利用自身真皮成纤维细胞和脐带间充质干细胞修补皮肤和软组织缺损的方法
CN102488930A (zh) * 2011-12-15 2012-06-13 无锡市第三人民医院 一种自异体表皮细胞混合悬液的制备方法
WO2013155109A1 (en) 2012-04-09 2013-10-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for generation of pluripotent and multipotent cells
ES2827049T3 (es) 2013-10-02 2021-05-19 Srgi Holdings Llc Dispositivos médicos de conjunto de píxeles
MX2016004331A (es) 2013-10-02 2016-11-10 Srgi Holdings Llc Dispositivos y metodos medicos de distribucion de pixeles.
US11229452B2 (en) 2013-12-06 2022-01-25 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US11937846B2 (en) 2013-12-06 2024-03-26 Srgi Holdings Llc Pixel array medical systems, devices and methods
JP2017521044A (ja) 2014-04-22 2017-08-03 キュー−ステート バイオサイエンシーズ， インコーポレイテッドＱ−Ｓｔａｔｅ Ｂｉｏｓｃｉｅｎｃｅｓ， Ｉｎｃ． 疼痛及び感覚障害のための化合物の分析
JP6805157B2 (ja) 2015-02-05 2020-12-23 エスアールジーアイ ホールディングス エルエルシーＳｒｇｉ Ｈｏｌｄｉｎｇｓ Ｌｌｃ ピクセルアレイ医療システム、デバイスおよび方法
US10048275B2 (en) 2015-03-13 2018-08-14 Q-State Biosciences, Inc. Cardiotoxicity screening methods
RU2578804C1 (ru) * 2015-04-27 2016-03-27 Екатерина Евгеньевна Фаустова Способ омоложения организма пациента
CA2986583A1 (en) 2015-05-21 2016-11-24 Q-State Biosciences, Inc. Optogenetics microscope
US11490952B2 (en) 2015-08-31 2022-11-08 Srgi Holdings, Llc Pixel array medical devices and methods
US11751903B2 (en) 2015-08-31 2023-09-12 Srgi Holdings, Llc Pixel array medical systems, devices and methods
US11564706B2 (en) 2019-10-28 2023-01-31 Srgi Holdings, Llc Pixel array medical systems, devices and methods
WO2020086915A2 (en) 2017-05-03 2020-04-30 Srgi Holdings Llc Handed spiral slotted scalpet array
WO2018217479A2 (en) 2017-05-11 2018-11-29 Srgi Holdings, Llc Systems, devices and methods for fractional resection, fractional skin grafting, fractional scar reduction and fractional tattoo removal
CN112334168B (zh) 2018-05-03 2024-10-22 科尔普兰特有限公司 真皮填充剂和其应用
GB202104130D0 (en) * 2021-03-24 2021-05-05 King S College London Method
EP4395796A4 (de) 2021-09-01 2024-12-25 Shanghai Qisheng Biological Preparation Co., Ltd. Knorpelregeneration mit injizierbaren, in situ polymerisierbaren collagenzusammensetzungen mit chondrozyten oder stammzellen
WO2023125689A1 (en) 2021-12-28 2023-07-06 Shanghai Qisheng Biological Preparation Co., Ltd. Hyaluronic acid-collagen copolymer compositions and medical applications thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949073A (en) * 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
US4488911A (en) * 1975-10-22 1984-12-18 Luck Edward E Non-antigenic collagen and articles of manufacture
US4424208A (en) * 1982-01-11 1984-01-03 Collagen Corporation Collagen implant material and method for augmenting soft tissue
US4582640A (en) * 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
US4609551A (en) * 1984-03-20 1986-09-02 Arnold Caplan Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites
US4642117A (en) * 1985-03-22 1987-02-10 Collagen Corporation Mechanically sheared collagen implant material and method
GB8708009D0 (en) * 1987-04-03 1987-05-07 Clayton Found Res Injectable soft tissue augmentation materials
US4969912A (en) * 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
GB2220593B (en) * 1988-06-09 1992-04-22 Cyclofil Hydro-cyclone
DE3829183A1 (de) * 1988-08-29 1990-03-08 Wella Ag Feeder-layer aus menschlichen bindegewebszellen, verfahren zu seiner herstellung sowie verfahren zur vermehrung menschlicher epithelzellen und deren verwendung zur restitution der haut
DE3837669C2 (de) * 1988-11-05 2001-12-13 Nikolaus W Klehr Verfahren zur Herstellung von Material für die Zelltherapie
EP0498992A3 (en) * 1991-02-15 1992-09-09 Nippon Oil Co., Ltd. Serum-free culture medium containing lysozyme
JP2774695B2 (ja) * 1991-03-29 1998-07-09 コラーゲン コーポレイション 顔のしわを処置する装置および方法
JPH06169761A (ja) * 1992-12-04 1994-06-21 Noevir Co Ltd 動物由来線維芽細胞の無血清培養用培地及び培養方法
AU740113B2 (en) * 1997-02-20 2001-11-01 Gerigene Medical Corporation Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects

Also Published As

Publication number Publication date
EP0845963B1 (de) 2003-09-24
KR19990035989A (ko) 1999-05-25
DE69630129D1 (de) 2003-10-30
CN100349556C (zh) 2007-11-21
IL123077A0 (en) 1998-09-24
NO317738B1 (no) 2004-12-13
JPH11510069A (ja) 1999-09-07
WO1997004720A1 (en) 1997-02-13
US5858390A (en) 1999-01-12
DE69630129T2 (de) 2004-04-08
IL123077A (en) 2003-07-06
PT845963E (pt) 2004-02-27
AU6451696A (en) 1997-02-26
ES2207679T3 (es) 2004-06-01
CA2228138C (en) 2007-09-11
US5660850A (en) 1997-08-26
JP2004105742A (ja) 2004-04-08
AU698440B2 (en) 1998-10-29
JP3962715B2 (ja) 2007-08-22
NZ312548A (en) 1999-11-29
EP1358857A1 (de) 2003-11-05
US5591444A (en) 1997-01-07
CN1198090A (zh) 1998-11-04
KR100417896B1 (ko) 2005-04-20
MX9800788A (es) 1998-11-30
CA2228138A1 (en) 1997-02-13
JP3559566B2 (ja) 2004-09-02
US5665372A (en) 1997-09-09
NO980356L (no) 1998-03-19
EP0845963A4 (de) 2000-11-02
NO980356D0 (no) 1998-01-27
EP0845963A1 (de) 1998-06-10
BR9610028A (pt) 1999-12-21
DK0845963T3 (da) 2004-01-26

Similar Documents

Publication Publication Date Title
ATE250399T1 (de) Gebrauch von autologen, dermalen fibroblasten zur reperatur von haut- oder weichgewebeschäden
ATE474052T1 (de) Verfahren zur herstellung von rekombinanten proteinen mittels inhibitoren von apoptose
DE60039454D1 (de) Eine zusammensetzung zur oxidationsfärbung von keratinischen fasern, die ein verdickungspolymer mit einer aminoplastether hauptkette enthält
AR005880A1 (es) Composicion y metodo para iluminar los parpados inferiores de los ojos.
ATE203520T1 (de) Kosmetische zusammensetzungen auf der basis von pyrazolin-4,5-dionen,neue pyrazolin-4,5-dionen, verfahren zu ihrer herstellung und ihrer verwendung
SG149002A1 (en) Hair growth method
DE3777580D1 (de) Kosmetisches mittel.
DE69031656D1 (de) Saccharinderivate zur verwendung als proteolytische enzyminhibitoren sowie verfahren zur herstellung
ATE514771T1 (de) Haartransplantation
ATE330621T1 (de) Materialen zur vermehrung von weichgewebe und deren herstellungs- und verwendungsmethoden
BR9815713A (pt) Método para aumento e reparo de defeitos de tecido dérmico, subcutâneo e das cordas vocais
PT1198557E (pt) Cultura melhorada de queeratinocito e suas utilizacoes
DE69016786D1 (de) Verwendung eines Koleusextrakts zur Hautpigmentierung.
DE59508843D1 (en) 2-fluor-6-nitroaniline
DE69013972D1 (de) Kosmetische Zusammensetzung.
MXPA03011253A (es) Composicion de tinte por oxidacion para fibras queratinas, que comprende alcohol graso, colorante de oxidacion, polimero asociativo y sulfato de alquilo con 14 a 30 atomos de carbono.
DE69132191D1 (de) Kosmetisches Verfahren zur Verringerung der Haarwuchsrate bei Säugetieren
DE69934399D1 (de) Komplex aus peptid und mhc-peptid auf oberfläche von phagen
BRPI0401190A (pt) Uso de uma composição, composição, processo para colorir as fibras queratìnicas humanas, processo para colorir pele escura e dispositivo com vários compartimentos
DE69712776D1 (de) Zusammensetzung zur dauerhaften verformung keratinischer fasern, ihre herstellung und anwendung
WO2003095630A3 (de) Bioartifizielle haut, die genetisch modifizierte fibroblasten aufweist
ATE149344T1 (de) Verwendung von hydroxynaphthalinen in färbemitteln
DE69412328D1 (de) Verwendung von Benzomorpholin-Derivaten in kosmetischen oder dermopharmaceutischen Zusammensetzungen zur Hautdepigmentierung
IT1282996B1 (it) Composizione cosmetica per rallentare la crescita e/o far scomparire i peli presenti in varie parti del corpo
ATE452144T1 (de) Verfahren zur herstellung von humaneigenblutzytokinen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0845963

Country of ref document: EP